<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590365/" ref="ordinalpos=3808&amp;ncbi_uid=4708021&amp;link_uid=PMC3590365" image-link="/pmc/articles/PMC3590365/figure/Fig2/" class="imagepopup">Fig. 2.  From: CCN2 exerts direct cytoprotective actions in adult cardiac myocytes by activation of the PI3-kinase/Akt/GSK-3? <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span>. </a></div><br /><div class="p4l_captionBody">Activation of Akt/GSK-3β signaling pathway by CCN2. <b>a</b> Western blot analysis of phospho-Akt (Ser473) and <b>b</b> phospho-GSK-3β (Ser9) contents in cardiac myocytes stimulated with increasing concentrations of rhCCN2 for 30 min. <b>c</b> Western blot analysis of phospho-glycogen synthase (Ser641) levels in cardiac myocytes stimulated with 250 nmol/L rhCCN2 for 24 and 40 h. The histograms demonstrate densitometric analysis of phospho-protein levels relative to respective total protein contents. Data are mean ± SEM of n = 3 in each group, *p &lt; 0.05 vs. control. The figure is representative of three independent experiments</div></div>